MiniMed Group, Inc. (MMED)
MiniMed Group will go public soon. The estimated IPO date is March 5, 2026.
IPO Price Range
$25.00 - $28.00
Shares Offered
28,000,000
Deal Size
$742.00M

Company Description

MiniMed Group is a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes.

Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes.

We address this market by offering various diabetes technologies, including insulin delivery devices (primarily insulin pumps and pens), continuous glucose monitors, other consumables, supplies, and related software and services.

MiniMed Group, Inc.
Country United States
Founded 1983
IPO Date Mar 5, 2026
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 8,000
CEO Que Dallara

Contact Details

Address:
18000 Devonshire St.
Northridge, CA 91325
United States
Phone (763) 514-4000
Website medtronicdiabetes.com

Stock Details

Ticker Symbol MMED
Exchange NASDAQ
Fiscal Year May - April
Reporting Currency USD
CIK Code 0002062583
Employer ID 33-3985981
SIC Code 3841

Key Executives

Name Position
Que Dallara Chief Executive Officer and Director Nominee
Chad Spooner Executive Vice President & Chief Financial Officer
Ali Dianaty Executive Vice President, Chief Product & Technology Officer
Courtney Nelson Wills Senior Vice President, General Counsel
Gillian Chandrasena Senior Vice President, Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Feb 27, 2026 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Feb 24, 2026 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Jan 23, 2026 S-1/A [Amend] General form for registration of securities under the Securities Act of 1933
Dec 19, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Oct 28, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Aug 27, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
May 30, 2025 DRS [Cover] Draft Registration Statement